A Phase I/II, Randomised, Multicentre, Placebo-controlled, Partially-blinded, Parallel-group Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU in Older Adults (Age 50 to 75 Years)
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 08 Aug 2018
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Eurocine
- 08 Aug 2018 Results presented in the Eurocine media release.
- 25 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Feb 2018 According to an Eurocine media release, study is planned to be conducted at five locations throughout Sweden during the present influenza season.